BridgeBio Pharma, Inc. (BBIO)
76.11
+2.83
(+3.86%)
USD |
NASDAQ |
Apr 27, 11:23
BridgeBio Pharma Market Cap : 14.75B for April 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 153.36B |
| Mirum Pharmaceuticals, Inc. | 5.742B |
| Insmed, Inc. | 29.78B |
| Eli Lilly & Co. | 786.15B |
| Vanda Pharmaceuticals, Inc. | 421.44M |
Market Cap Related Metrics
| PS Ratio | 29.03 |
| PEG Ratio | -0.6113 |
| Price | 76.11 |
| Earnings Yield | -4.97% |
| PEGY Ratio | -0.6113 |